Portugal · Pharmaceuticals startup

INEYE THERAPEUTICS

INEYE THERAPEUTICS S.A.

Funding reportedLast round: Seed

PharmaceuticalsCoimbra, Portugal

About INEYE THERAPEUTICS

INEYE THERAPEUTICS S.A.

is a healthcare and life sciences company based in Coimbra, Portugal. The company focuses on enhancing quality of life by preventing blindness and visual impairment through innovative medical devices and pharmaceutical products. Its primary work revolves around ophthalmic drug-delivery technology, particularly the InEye® platform, which releases flurbiprofen and moxifloxacin at controlled rates. INEYE THERAPEUTICS operates as a research and development and product-development company in the field of ophthalmology. It is advancing technologies from development to clinical evaluation and commercialization. The company is engaged in ongoing research and clinical-trial preparation, with a roadmap that includes testing InEye® formulations for specific treatments. Its publicly advertised products include the InEye® ophthalmic delivery system and related drug-device concepts aimed at treating eye diseases. The company collaborates with institutions like ULS Coimbra on various projects.

What company datasets say INEYE THERAPEUTICS raised

Funding, as reported

Reported in all110kin the source's currency
Last roundSeed
Last round size110k
Last round dateSept 2023

Founders and team

From INEYE THERAPEUTICS's own website: 2 founders, 2 on the team.

Marcos MarizCEO & Co-founder
Paula FerreiraCSO & Co-founder
  • Sandra AlmeidaQuality Manager
  • Teresa CernadasProduct Manager

AdvisersHelena GilJoaquim Murta

The company, in detail

What they build

Known for

medicalpharmaceuticalspharmaceutical manufacturing

Built with from their website

Microsoft ExchangeMicrosoft 365 Apps & ServicesMicrosoft Exchange OnlineMicrosoft 365OutlookMicrosoft Email ProvidersGoogle Search Console

Sector
Pharmaceuticals
Region
Coimbra District

Pharmaceuticals in Portugal

Startups like it

Is this your company?

Add your raise, your deck and your story, and put INEYE THERAPEUTICS in front of investors. Or tell us what we have wrong.